LAM
BIIB icon

L2 Asset Management’s Biogen BIIB Stock Holding History

L2 Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-101
Closed -$2.29M – 184
2023
Q3 		$2.29M Sell
101
-8,421
-99% -$2.25M 1.08% 32
2023
Q2 		$2.43M Buy
+8,522
New +$2.54M 1.19% 31
2021
Q2 		– Sell
-4,294
Closed -$1.2M – 96
2021
Q1 		$1.2M Sell
4,294
-1,976
-32% -$533K 1.24% 34
2020
Q4 		$1.53M Sell
6,270
-3,056
-33% -$788K 1.05% 29
2020
Q3 		$2.65M Sell
9,326
-66
-0.7% -$18.4K 2.13% 8
2020
Q2 		$2.51M Sell
9,392
-460
-5% -$138K 2.28% 16
2020
Q1 		$3.12M Sell
9,852
-808
-8% -$245K 3.5% 3
2019
Q4 		$3.16M Buy
+10,660
New +$2.96M 2.77% 4

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

L2 Asset Management's BIIB Position: Q4 2023 in Review

L2 Asset Management sold out of Biogen (BIIB) in Q4 2023, closing a stake of 101 shares — an estimated $2.29M sold.

L2 Asset Management first reported a position in BIIB in Q4 2019 and held it in 8 quarters. The position peaked at $3.16M in Q4 2019. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • L2 Asset Management reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • L2 Asset Management sold 101 Biogen shares in Q4 2023, an estimated $2.29M.
  • L2 Asset Management first reported a position in Biogen in Q4 2019 and held it in 8 quarters.
  • L2 Asset Management's Biogen position peaked at $3.16M in Q4 2019.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on L2 Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.